Promisemed VeriEcto Automatic Biopsy Needles— 510(k) K261196

Substantially Equivalent

Promisemed Hangzhou Meditech Co., Ltd.

FDA 510(k) clearance K261196 for Promisemed VeriEcto Automatic Biopsy Needles, Substantially Equivalent on 2026-05-12. Applicant: Promisemed Hangzhou Meditech Co., Ltd.. Device class: 2.

Summary

Promisemed Hangzhou Meditech's Promisemed VeriEcto Automatic Biopsy Needles are filed under KNW, biopsy instruments.

Class II, 21 CFR 876.1075. The General and Plastic Surgery review panel handled it as a Special 510(k), though the record lists Gastroenterology and Urology as the classification panel.

Promisemed filed from Hangzhou City, China. Review took 29 calendar days (April 13 to May 12, 2026).

Clearance details

Applicant
Promisemed Hangzhou Meditech Co., Ltd.
Product code
Product code KNW
Device class
Class 2
Regulation
21 CFR 876.1075
Advisory panel
Gastroenterology, Urology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Hangzhou City, CN
Download summary PDFView on FDA.gov ↗

Recent devices under product code KNW

view all

More clearances from Promisemed Hangzhou Meditech Co., Ltd.

view all

Adverse events under product code KNW

product code KNW
Death
9
Injury
965
Malfunction
10,444
Other
3
Total
11,421

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.